Antibacterial activity of silver nanoparticles against Escherichia coli and methicillin-resistant Staphylococcus pseudintermedius is affected by incorporation into carriers for sustained release.
Miriam G BatesMarije RisseladaDaniela C Peña-HernandezKenitra HendrixGeorge E MoorePublished in: American journal of veterinary research (2024)
AgNP has antibacterial activity against E coli and MRSP, which can be reduced when incorporated into carriers for sustained release. Poloxamer 407 gel alone and combined with AgNP exerts antibacterial activity against E coli and MRSP.